U K appeals court affirms HC ruling in Ranbaxy-Pfizer case
28 Jun 2006
1
Speaking...
Mumbai: The UK Court of Appeal has upheld an October 2005 ruling of the UK High Court in Ranbaxy Laboratories' case against (Pfizer) Warner-Lambert over the cholesterol-lowering drug, atorvastatin, which is marketed by Pfizer as Lipitor, Ranbaxy said on Wednesday. The three-judge panel confirmed that (Pfizer) Warner-Lambert's European Patent 409 281 was invalid in the UK. However, the company's atorvastatin product was ruled to infringe the broadest claims of (Pfizer) Warner-Lambert's European patent 247 633 in the UK. The company is evaluating this decision and will decide on its course of action shortly.
.webp)
